Cite
A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.
MLA
Chen, Andrew C., et al. “A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.” New England Journal of Medicine, vol. 373, no. 17, Oct. 2015, pp. 1618–26. EBSCOhost, https://doi.org/10.1056/NEJMoa1506197.
APA
Chen, A. C., Martin, A. J., Choy, B., Fernández-Peñas, P., Dalziell, R. A., McKenzie, C. A., Scolyer, R. A., Dhillon, H. M., Vardy, J. L., Kricker, A., George, G. S., Chinniah, N., Halliday, G. M., Damian, D. L., & St George, G. (2015). A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention. New England Journal of Medicine, 373(17), 1618–1626. https://doi.org/10.1056/NEJMoa1506197
Chicago
Chen, Andrew C., Andrew J. Martin, Bonita Choy, Pablo Fernández-Peñas, Robyn A. Dalziell, Catriona A. McKenzie, Richard A. Scolyer, et al. 2015. “A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.” New England Journal of Medicine 373 (17): 1618–26. doi:10.1056/NEJMoa1506197.